Old Web
English
Sign In
Acemap
>
Paper
>
Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes
Relapsed or Refractory CLL after CD19-Specific CAR-T Therapy: Treatment Patterns and Clinical Outcomes
2019
Mazyar Shadman
Jordan Gauthier
Sirin Khajavian
Alexandre V. Hirayama
Ryan C. Lynch
Stephen D. Smith
Chaitra S. Ujjani
Victor A. Chow
Hans Peter Kiem
Brian G. Till
Ajay K. Gopal
David G. Maloney
Cameron J. Turtle
Keywords:
Oncology
Internal medicine
Immunology
Refractory CLL
Medicine
CD19
Fludarabine
Cytokine release syndrome
Idelalisib
Transplantation
Chimeric Antigen Receptor T-Cell Therapy
Venetoclax
Chemotherapy regimen
Ibrutinib
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
3
Citations
NaN
KQI
[]